Benchmark Holdings

We’re boosting the biological performance of fish and shrimp to drive productivity, profitability and sustainability in food production.


Benchmark Holdings is a leading aquaculture biotechnology company. Together we are enabling aquaculture producers to improve their sustainability and profitability by providing products and solutions in genetics, advanced nutrition and health which improve yield, quality and animal welfare

Focussing on salmon, shrimp, bass and bream, Benchmark is present in every major aquaculture market with customers in 70 countries. In 2013, Benchmark was listed on the AIM market of the London Stock Exchange.

Benchmark has a broad portfolio of products including sophisticated genetics which improve yield and disease resistance, advanced nutrition solutions which deliver growth and resilience, and sea lice treatments which are helping to address the biggest biological challenge in salmon production.

Its breakthroughs include the adoption of human cancer cell screening techniques to enable earlier disease identification in aquaculture, reducing waste and antibiotic use.

In 2019, Benchmark received the Aquaculture Innovation Award for CleanTreat, a water purification system that removes medicines from treatment water before releasing it back into the sea.

Find out more.

Grosvenor Food & AgTech is an ideal shareholder. Their knowledge of the aquaculture sector has been hugely helpful in focussing our offering.


Trond Williksen
Chief Executive Officer, Benchmark Holdings PLC


For more information on Grosvenor Food & AgTech's investment in Benchmark Holdings please contact:

image of Anthony James

Anthony James

Managing Partner, Grosvenor Food & AgTech

+44 1244 670981

Related content

Group 2